University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Sexual and Gender Minority Emerging Adults Eliciting Narratives

Not Applicable

Completed

Conditions: Sexual Orientation
Gender Identity
Mental Health Wellness 1

Interventions: Behavioral: Critical Narrative Development

First Posted Date: 2023-06-12

Last Posted Date: 2024-11-25

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 20

Registration Number: NCT05899218

Locations: 🇺🇸
School of Nursing, University of Pennsylvania, Philadelphia, Pennsylvania, United States

Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement

Not Applicable

Recruiting

Conditions: Opioid Use Disorder
Opioid Dependence with Current Use (Disorder)

Interventions: Behavioral: Contingency Management
Behavioral: Text Message Check-ins

First Posted Date: 2023-06-09

Last Posted Date: 2024-08-02

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 1649

Registration Number: NCT05897788

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Sleep Deprivation

Completed

Conditions: Major Depressive Disorder

Interventions: Behavioral: Sleep Deprivation

First Posted Date: 2023-06-07

Last Posted Date: 2025-02-27

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 3

Registration Number: NCT05893173

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure

Conditions: Heart Failure NYHA Class III
Heart Failure NYHA Class II
Heart Failure

First Posted Date: 2023-06-02

Last Posted Date: 2024-07-24

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 40

Registration Number: NCT05885607

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Imaging Inflammation With Alcohol Use Disorder: an [18F]NOS Study

Early Phase 1

Recruiting

Conditions: Alcohol Use Disorder

Interventions: Drug: [18F]NOS

First Posted Date: 2023-06-02

Last Posted Date: 2024-08-23

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 90

Registration Number: NCT05885594

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Vessel Wall Enhancement in Giant Cell Arteritis

Recruiting

Conditions: Giant Cell Arteritis

Interventions: Diagnostic Test: Magnetic Resonance Imaging (MRI)

First Posted Date: 2023-05-18

Last Posted Date: 2024-06-11

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 400

Registration Number: NCT05865054

Locations: 🇺🇸
3400 Civic Center Blvd, Philadelphia, Pennsylvania, United States

Cash Transfers to Address Child Welfare Involvement

Not Applicable

Completed

Conditions: Child Poverty

Interventions: Other: Unconditional Cash Transfer
Other: No Direct Cash Transfer

First Posted Date: 2023-05-12

Last Posted Date: 2025-01-28

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 450

Registration Number: NCT05857553

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Disentangling the Role of Depression in Hypersomnia

Recruiting

Conditions: Hypersomnia

Interventions: Diagnostic Test: Sleep study

First Posted Date: 2023-05-09

Last Posted Date: 2024-08-20

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 45

Registration Number: NCT05850676

Locations: 🇺🇸
The University of Pennsylvania, Philadelphia, Pennsylvania, United States

Remote Pregnancy Monitoring to Improve Access

Not Applicable

Active, not recruiting

Conditions: Fetal Monitoring

Interventions: Device: Invu monitoring belt
Other: Standard of care

First Posted Date: 2023-05-08

Last Posted Date: 2025-05-11

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 400

Registration Number: NCT05847790

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Solriamfetol and CBT-I in Patients With Insomnia Disorder

Phase 4

Active, not recruiting

Conditions: Insomnia

Interventions: Drug: Solriamfetol 75 MG
Behavioral: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Other: Monitoring
Other: Placebo

First Posted Date: 2023-05-01

Last Posted Date: 2025-05-21

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 60

Registration Number: NCT05838430

Locations: 🇺🇸
University of Pennsylvania, Behavioral Sleep Medicine Program, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy